Improving In-hospital Stroke Service Utilisation in China

Summary

A cluster randomised controlled trial will be conducted, using hospital as randomisation unit. Hospitals in Zhejiang Province, China, will be randomised into two arms (1:1): an intervention arm and a control arm. Hospitals in the intervention arm will receive a multi-components intervention based on the Behaviour Change Wheel model, whereas hospitals in the control arm will receive no intervention and maintain existing care. The randomisation will be conducted after one-year baseline data collection. The following baseline data will be used for randomisation match: hospital classification, beds in stroke centre, thrombolysis patient number, and percentage of patients receiving thrombolysis within 60 minutes of stroke onset. Hospitals with no stroke centre or with \<20 cases received thrombolysis per year will be excluded from the study. The primary outcome will be difference between intervention arm and control arm in the percentage of patients receiving thrombolysis within 60 minutes of stroke onset on the follow-up stage (post-intervention).

Conditions

• Thrombolytic Therapy
• Acute Stroke
• Door to Treatment Time
• Quality Improvement

Interventions

BEHAVIORAL

Behaviour Change Wheel model guided intervention

Interventions are developed on a psychological model, the Behaviour Change Wheel (BCW) .The fundamental of BCW consists of three essential elements: capability, motivation, and opportunity. Improving individual's capability, providing motivation, and increasing opportunities are goals of behaviour change intervention. To achieve the goals, 9 intervention components have been proposed in the BCW framework, and 6 components will be used in current study.

Sponsors & Collaborators

• Shaoxing Second Hospital

  collaborator OTHER

• Haining People' s Hospital

  collaborator UNKNOWN

• Haiyan People' s Hospital

  collaborator UNKNOWN

• Huzhou No.1 People' s Hospital

  collaborator UNKNOWN

• Jiashan No.1 People' s Hospital

  collaborator UNKNOWN

• Ningbo Medical Center Lihuili Hospital

  collaborator OTHER_GOV

• Tongxiang No.1 People' s Hospital

  collaborator UNKNOWN

• First Affiliated Hospital of Wenzhou Medical University

  collaborator OTHER

• Yiwu Central Hospital

  collaborator OTHER

• Yongkang No.1 People' s Hospital

  collaborator UNKNOWN

• Yuyao People's Hospital

  collaborator OTHER

• Deqing People' s Hospital

  collaborator UNKNOWN

• Dongyang People's Hospital

  collaborator OTHER

• Jinhua People' s Hospital

  collaborator UNKNOWN

• Lishui People' s Hospital

  collaborator UNKNOWN

• Lin' an People' s Hospital

  collaborator UNKNOWN

• Longquan People' s Hospital

  collaborator UNKNOWN

• Qingtian People' s Hospital

  collaborator UNKNOWN

• Shaoxing Central Hospital

  collaborator OTHER

• Wenzhou Central Hospital

  collaborator OTHER

• Xiangshan No.1 People' s Hospital

  collaborator UNKNOWN

• The Central Hospital of Lishui City

  collaborator OTHER

• Second Affiliated Hospital, School of Medicine, Zhejiang University

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-01-01

Primary Completion

2019-12-31

Completion

2020-06-30

Countries

• China

Study Locations